Evidence map›Paper›PMID 36397060›Full record

Trial reportRadiation oncology (London, England)2022

Radiation pneumonitis prediction after stereotactic body radiation therapy based on 3D dose distribution: dosiomics and/or deep learning-based radiomics features.

Ying Huang, Aihui Feng, Yang Lin, Hengle Gu, Hua Chen, Hao Wang, Yan Shao, Yanhua Duan, Weihai Zhuo, Zhiyong Xu

Open access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Radiation oncology (London, England), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 1 pooled it
5.3field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 1 synthesis or guideline pooled it, 39 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Ying HuangShanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, 200030, China.
Aihui FengShanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, 200030, China.
Yang LinShanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, 200030, China.
Hengle GuShanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, 200030, China.
Hua ChenShanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, 200030, China.
Hao WangShanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, 200030, China.
Yan ShaoShanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, 200030, China.
Yanhua DuanShanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, 200030, China.
Weihai ZhuoDepartment of Nuclear Science and Technology, Institute of Modern Physics, Fudan University, Shanghai, China.
Zhiyong XuShanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, 200030, China. xzyong12vip@sina.com.
Shanghai Jiao Tong University · CNFudan University · CNShanghai Chest Hospital · CNInstitute of Modern Physics · CN

Funding

Science and Technology Innovation Plan Of Shanghai Science and Technology Commission No.22YF1442600
6 · The paper itself

Abstract

backgroundThis study was designed to establish radiation pneumonitis (RP) prediction models using dosiomics and/or deep learning-based radiomics (DLR) features based on 3D dose distribution.

methodsA total of 140 patients with non-small cell lung cancer who received stereotactic body radiation therapy (SBRT) were retrospectively included in this study. These patients were randomly divided into the training (n = 112) and test (n = 28) sets. Besides, 107 dosiomics features were extracted by Pyradiomics, and 1316 DLR features were extracted by ResNet50. Feature visualization was performed based on Spearman's correlation coefficients, and feature selection was performed based on the least absolute shrinkage and selection operator. Three different models were constructed based on random forest, including (1) a dosiomics model (a model constructed based on dosiomics features), (2) a DLR model (a model constructed based on DLR features), and (3) a hybrid model (a model constructed based on dosiomics and DLR features). Subsequently, the performance of these three models was compared with receiver operating characteristic curves. Finally, these dosiomics and DLR features were analyzed with Spearman's correlation coefficients.

resultsIn the training set, the area under the curve (AUC) of the dosiomics, DLR, and hybrid models was 0.9986, 0.9992, and 0.9993, respectively; the accuracy of these three models was 0.9643, 0.9464, and 0.9642, respectively. In the test set, the AUC of these three models was 0.8462, 0.8750, and 0.9000, respectively; the accuracy of these three models was 0.8214, 0.7857, and 0.8571, respectively. The hybrid model based on dosiomics and DLR features outperformed other two models. Correlation analysis between dosiomics features and DLR features showed weak correlations. The dosiomics features that correlated DLR features with the Spearman's rho |ρ| ≥ 0.8 were all first-order features.

conclusionThe hybrid features based on dosiomics and DLR features from 3D dose distribution could improve the performance of RP prediction after SBRT.

Indexed as

Carcinoma, Non-Small-Cell LungDeep LearningLung NeoplasmsRadiation PneumonitisRadiosurgeryHumansRetrospective Studies3D dose distributionDeep learning-based radiomicsDosiomicsRadiation pneumonitis predictionRandom forest

Identifiers

PMID36397060
PMCPMC9673306
OpenAlexW4309232524

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.